Cyteir Therapeutics Announces First Patient Dosed in Phase 2 with CYT-0851

Feb 08, 2022

Posted by Cyteir Therapeutics

Medical Device Companies Take Note: FDA’s Proposed Rule to Align ISO 13485 With its Quality System Regulation Moves Forward

Feb 07, 2022

Posted by Sidley Austin

Cyteir Therapeutics Announces the Appointment of John F. Thero to Board of Directors

Feb 07, 2022

Posted by Cyteir Therapeutics

Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI

Feb 02, 2022

Syner-G BioPharma Group Acquires Impact; Expands Services for Biotech and Pharma Companies

Feb 01, 2022

Posted by Syner-G BioPharma Group

What Healthcare Providers and Life Sciences Companies Can Expect for Enforcement in 2022

Feb 01, 2022

Posted by Sidley Austin

Proposed Bill Seeks to Eliminate Preannounced Foreign Drug Inspections

Feb 01, 2022

Posted by Sidley Austin

Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Jan 31, 2022

Posted by FUJIFILM Diosynth Biotechnologies